|
Volumn 170, Issue 3, 2016, Pages 703-706
|
KIAA2022 nonsense mutation in a symptomatic female
|
Author keywords
Autism; Epilepsy; Intellectual disability; KIAA2022; X inactivation; X linked
|
Indexed keywords
CARBAMAZEPINE;
CLOBAZAM;
CLORAZEPATE;
ETIRACETAM;
HARKOSERIDE;
LAMOTRIGINE;
RUFINAMIDE;
TOPIRAMATE;
VALPROATE SEMISODIUM;
NERVE PROTEIN;
STOP CODON;
XPN PROTEIN, HUMAN;
ABSENCE;
ADOLESCENT;
ARTICLE;
ATONIC DROP;
AUTISM;
CASE REPORT;
DISEASE SEVERITY;
EPILEPSY;
FEMALE;
GENE;
GENERAL ASPECTS OF DISEASE;
HUMAN;
INTELLECTUAL IMPAIRMENT;
KIAA2022 GENE;
MEDICAL HISTORY;
MICROCEPHALY;
MUTATIONAL ANALYSIS;
NON SYNDROMIC X LINKED INTELLECTUAL DISABILITY;
NONSENSE MUTATION;
PHENOTYPE;
PRIORITY JOURNAL;
SEIZURE;
SEIZURE FREQUENCY;
SHORT STATURE;
SPEECH DISORDER;
TONIC CLONIC SEIZURE;
TONIC SEIZURE;
X CHROMOSOME INACTIVATION;
DWARFISM;
FACIES;
GENETIC ASSOCIATION STUDY;
GENETICS;
INTELLECTUAL DISABILITY;
STOP CODON;
ADOLESCENT;
CODON, NONSENSE;
DWARFISM;
EPILEPSY;
FACIES;
FEMALE;
GENETIC ASSOCIATION STUDIES;
HUMANS;
INTELLECTUAL DISABILITY;
NERVE TISSUE PROTEINS;
PHENOTYPE;
|
EID: 84959522680
PISSN: 15524825
EISSN: 15524833
Source Type: Journal
DOI: 10.1002/ajmg.a.37479 Document Type: Article |
Times cited : (24)
|
References (7)
|